Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
BROMAZEPAM ARENA 3 mg
Anxiolytic from the benzodiazepine class, indicated in the treatment of anxiety disorders
Active Substance (INN)
BROMAZEPAMUM
Packaging
1 blister x 10 tablets
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.